Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor

Journal of Immunology

Volumn 172, Issue 11, 2004, Pages 7078-7085

  Ying, Guoguang ^a   Iribarren, Pablo ^a   Zhou, Ye ^a   Gong, Wanghua ^a   Zhang, Ning ^a   Yu, Zu Xi ^b   Le, Yingying ^a   Cui, Youhong ^a   Wang, Ji Ming ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CALCIUM ION; COMPLEMENTARY DNA; FORMYLPEPTIDE; G PROTEIN COUPLED RECEPTOR; HUMANIN; NEUROPROTECTIVE AGENT; RNA; SYNTHETIC PEPTIDE;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CALCIUM MOBILIZATION; CHEMOTAXIS; CONFOCAL MICROSCOPY; CYTOTOXICITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; INFLAMMATION; MICROGLIA; MONOCYTE; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; PHAGOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 2442705358     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.11.7078     Document Type: Article

References (39)

1. Selkoe, D. J. 1999. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399(Suppl. A23):6738.
2. 1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95:6448.
3. Hartley, D. M., D. M. Walsh, C. P. Ye, T. Diehl, S. Vasquez, P. M. Vassilev, D. B. Teplow, and D. J. Selkoe. 1999. Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19:8876.
4. Lorenzo, A., and B. A. Yankner. 1994 β-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. USA 91:12243.
5. Klein, W. L., G. A. Krafft, and C. E. Finch. 2001. Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24:219.
6. Pachter, J. S. 1997. Inflammatory mechanisms in Alzheimer disease: the role of β-amyloid/glial interactions. Mol. Psychiatry 2:91.
7. London, J. A., D. Biegel, and J. S. Pachter. 1996. Neurocytopathic effects of β-amyloid-stimulated monocytes: a potential mechanism for central nervous system damage in Alzheimer disease. Proc. Natl. Acad. Sci. USA 93:4147.
8. Neuroinflammation Working Group. 2000. Inflammation and Alzheimer's disease. Neurobiol. Aging 21:383.
9. 42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages. FASEB J. 15:2454.
10. Yan, S. D., X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, et al. 1996. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382:685.
11. El Khoury, J., S. E. Hickman, C. A. Thomas, J. D. Loike, and S. C. Silverstein. 1998. Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease. Neurobiol. Aging 19(Suppl. 1):S81.
12. Wang, H. Y., D. H. Lee, M. R. D'Andrea, P. A. Peterson, R. P. Shank, and A. B. Reitz. 2000. β-Amyloid(1-42) binds to α7 nicotinic acetylcholine receptor with high affinity: implications for Alzheimer's disease pathology. J. Biol. Chem. 275:5626.
13. LaDu, M. J., J. A. Shah, C. A. Reardon, G. S. Getz, G. Bu, J. Hu, L. Guo, and L. J. van Eldik. 2000. Apolipoprotein E receptors mediate the effects of β-amyloid on astrocyte cultures. J. Biol. Chem. 275:33974.
14. Liu, Q., H. Kawai, and D. K. Berg. 2001. β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons. Proc. Natl. Acad. Sci. USA 98:4734.
15. Xie, L., E. Helmerhorst, K. Taddei, B. Plewright, W. Van Bronswijk, and R. Martins. 2002. Alzheimer's β-amyloid peptides compete for insulin binding to the insulin receptor. J. Neurosci. 22:RC221.
16. Dechant, G., and Y. A. Barde. 2002. The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. Nat. Neurosci. 5:1131.
17. Le, Y., W. Gong, H. L. Tiffany, A. Tumanov, S. Nedospasov, W. Shen, N. M. Dunlop, J. L. Gao, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 2001. Amyloid (β)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J. Neurosci. 21:RC123.
18. Tiffany, H. L., M. C. Lavigne, Y. H. Cui, J. M. Wang, T. L. Leto, J. L. Gao, and P. M. Murphy. 2001. Amyloid-β induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain. J. Biol. Chem. 276:23645.
19. Prossnitz, E. R., and R. D. Ye. 1997. The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function. Pharmacol. Ther. 74:73.
20. Le, Y., P. M. Murphy, and J. M. Wang. 2002. Formyl-peptide receptors revisited. Trends Immunol. 23:541.
21. Cui, Y. H., Y. Le, W. Gong, P. Proost, J. Van Damme, W. J. Murphy, and J. M. Wang. 2002. Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells. J. Immunol. 168:434.
22. Hashimoto, Y., T. Niikura, H. Tajima, T. Yasukawa, H. Sudo, Y. Ito, Y. Kita, M. Kawasumi, K. Kouyama, M. Doyu, et al. 2001. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ. Proc. Natl. Acad. Sci. USA 98:6336.
23. Tajima, H., T. Niikura, Y. Hashimoto, Y. Ito, Y. Kita, K. Terashita, K. Yamazaki, A. Koto, S. Aiso, and I. Nishimoto. 2002. Evidence for in vivo production of Humanin peptide, a neuroprotective factor against Alzheimer's disease-related insults. Neurosci. Lett. 324:227.
24. Le, Y., W. Gong, B. Li, N. M. Dunlop, W. Shen, S. B. Su, R. D. Ye, and J. M. Wang. 1999. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J. Immunol. 163:6777.
25. Hu, J. Y., Y. Le, W. Gong, N. M. Dunlop, J. L. Gao, P. M. Murphy, and J. M. Wang. 2001. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1. J. Leukocyte Biol. 70:155.
26. Su, S. B., W. Gong, J. L. Gao, W. Shen, M. C. Grimm, X. Deng, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 1999. T20/DP178, an ectodomain peptide of human immunodeficiency virus type 1 gp41, is an activator of human phagocyte N-formyl peptide receptor. Blood 93:3885.
27. 42), in murine microglial cells by TNFα. Neurobiol. Dis. 10:366.
28. Le, Y., J. Hu, W. Gong, W. Shen, B. Li, N. M. Dunlop, D. O. Halverson, D. G. Blair, and J. M. Wang. 2000. Expression of functional formyl peptide receptors by human astrocytoma cell lines. J. Neuroimmunol. 111:102.
29. Wei, W., X. Wang, and J. W. Kusiak. 2002. Signaling events in amyloid β-peptide-induced neuronal death and insulin-like growth factor I protection. J. Biol. Chem. 277:17649.
30. Deng, X., H. Ueda, S. B. Su, W. Gong, N. M. Dunlop, J. L. Gao, P. M. Murphy, and J. M. Wang. 1999. A synthetic peptide derived from human immunodeficiency virus type 1 gp120 down-regulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R. Blood 94:1165.
31. Su, S. B., J. L. Gao, W. Gong, N. M. Dunlop, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 1999. T21/DP107, a synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors. J. Immunol. 162:5924.
32. 106-126 is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1. J. Immunol. 166:1448.
33. Su, S. B., W. Gong, J. L. Gao, W. Shen, P. M. Murphy, J. J. Oppenheim, and J. M. Wang, 1999, A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189:395.
34. Cui, Y. H., Y. Le, H. Yazawa, W. Gong, and J. M. Wang. 2002. Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease. J. Leukocyte Biol. 72:628.
35. Hashimoto, Y., T. Niikura, Y. Ito, H. Sudo, M. Hata, E. Arakawa, Y. Abe, Y. Kita, and I. Nishimoto. 2001. Detailed characterization of neuroprotection by a rescue factor Humanin against various Alzheimer's disease-relevant insults. J. Neurosci. 21:9235.
36. Kariya, S., N. Takahash, N. Ooba, M. Kawahara, H. Nakayama, and S. Ueno. 2002. Humanin inhibits cell death of serum-deprived PC12h cells. NeuroReport 13:903.
37. 14]-Humanin improved the leaming and memory impairment induced by scopolamine in vivo. Br. J. Pharmacol. 134:1597.
38. Guo, B., D. Zhai, E. Cabezas, K. Welsh, S. Nouraini, A. C. Satterthwait, and J. C. Reed. 2003. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 423:456.
39. Tsukamoto, E., Y. Hashimoto, K. Kanekura, T. Niikura, S. Aiso, and I. Nishimoto. 2003. Characterization of the toxic mechanism triggered by Alzheimer's amyloid-β peptides via p75 neurotrophin receptor in neuronal hybrid cells. J. Neurosci. Res. 73:627.